ClinicalTrials.gov
public full text
Public Domain
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID-19 or other potential viral and bacterial pathogens.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICU#896352
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome#6150
- The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease#159200
- Pulmonary and cerebral damage in COVID-19 survivors: is there any association?#295244
- Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients#884128
Record · ID 865158
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive